Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ONXX -- Ignore unavailable to you. Want to Upgrade?

To: Skywatcher who wrote (383)	8/1/2000 12:41:35 PM
From: Charles Tutt	Read Replies (1) \| Respond to of 810

200? I wish!

To: Skywatcher who wrote (383)	8/1/2000 2:38:45 PM
From: Elmer	Respond to of 810

Funny that you mentioned IDEC. I owned it during phase III trials expecting that it would get a major pop. It didn't. So, I sold, which means I left 14 times on the table in about four years. This may do the same after phase III. But if the trials are successful and they platform the technology into other cancer therapeutics, it could make IDEC look like a modest performer. Finally, CNBC has been talking about the company all day. They said that only one analyst covers it. If the Street starts coverage and it's positive, a few brave institutions may venture forth and create some demand. I hope so. I bought some for my Mom today.